Chai Yi, Pistorius Dominik, Ullrich Angelika, Weissman Kira J, Kazmaier Uli, Müller Rolf
Department of Pharmaceutical Biotechnology, Saarland University, P.O. Box 151150, 66041 Saarbrücken, Germany.
Chem Biol. 2010 Mar 26;17(3):296-309. doi: 10.1016/j.chembiol.2010.01.016.
The tubulysins are a family of complex peptides with promising cytotoxic activity against multi-drug-resistant tumors. To date, ten tubulysins have been described from the myxobacterial strains Angiococcus disciformis An d48 and Archangium gephyra Ar 315. We report here a third producing strain, Cystobacter sp. SBCb004. Comparison of the tubulysin biosynthetic gene clusters in SBCb004 and An d48 reveals a conserved architecture, allowing the assignment of cluster boundaries. A SBCb004 strain containing a mutant in the putative cyclodeaminase gene tubZ accumulates pretubulysin A, the proposed first enzyme-free intermediate in the pathway, whose structure we confirm by NMR. We further show, using a combination of feeding studies and structure elucidation by NMR and high-resolution tandem mass spectrometry, that SBCb004 and An d48 together biosynthesize 22 additional tubulysin derivatives. These data reveal the inherently diversity-oriented nature of the tubulysin biosynthetic pathway.
微管溶素是一类复杂的肽,对多药耐药肿瘤具有有前景的细胞毒性活性。迄今为止,已从粘细菌菌株盘状血管球菌An d48和鳃状原囊菌Ar 315中描述了十种微管溶素。我们在此报告第三个产生菌株,即囊杆菌属SBCb004。对SBCb004和An d48中微管溶素生物合成基因簇的比较揭示了一种保守的结构,从而能够确定簇边界。在假定的环脱氨酶基因tubZ中含有突变的SBCb004菌株积累了前微管溶素A,它是该途径中推测的首个无酶中间体,我们通过核磁共振(NMR)确定了其结构。我们进一步通过饲喂研究以及核磁共振和高分辨率串联质谱的结构解析相结合的方法表明,SBCb004和An d48共同生物合成了另外22种微管溶素衍生物。这些数据揭示了微管溶素生物合成途径固有的多样化性质。